Skip to main content
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: Cancer Res. 2021 Nov 23;82(2):199–209. doi: 10.1158/0008-5472.CAN-21-1903

Figure 5. Signatures of CH mutations.

Figure 5

(A) Overall mutational signature of CH mutations. (B) Proportion of mutations attributed to signatures, which were assigned previously by Alexandrov et. al (23). Signature 3 and Signature 4 contributed most to the total mutational signature. (C) Rates of nucleotide substitution of Signature 3 and Signature 4. Data came from Alexandrov et. al (23). (D) Lung cancer patients had lower proportion of Signature 3. (E) Smoker had higher fraction of Signature 4.